RAC2 and PSMB9 have been revealed to be associated with disease development from MGUS to multiple myeloma (23, 24) and our analysis suggested that they might also be related to multiple myeloma rapid progression, supported by both scRNA-seq and CITE-seq. Here, PSMB9 is linked to plasma cell myeloma.